Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia
Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia is a paper indexed in PICO Portal from OpenAlex.
How many citations does Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia have?
Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia has 156 citations in the OpenAlex counts PICO Portal stores.
When was Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia published?
Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia has 2015 year in the PICO Portal index.
What is the open-access status of Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia?
Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia has closed oa status in the PICO Portal index.
What is the DOI of Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia?
The DOI for Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia is on the source record.
What is the PMID of Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia?
The PMID for Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia is on the source record.
What is the OpenAlex record for Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia?
The OpenAlex for Zearalenone and its metabolites in urine and breast cancer risk: A case-control study in Tunisia is on the source record.